Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 5
2004 2
2006 1
2008 1
2009 1
2010 1
2012 1
2013 1
2016 2
2017 1
2018 1
2020 6
2021 11
2022 11
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.
Romera Martínez I, Avendaño-Solá C, Villegas Da Ros C, Bosch Llobet A, García Erce JA, González Fraile MI, Guerra Domínguez L, Vicuña Andrés I, Anguita Velasco J, González Rodríguez VP, Contreras E, Urcelay Uranga S, Pajares Herraiz ÁL, Jimenez-Marco T, Ojea Pérez AM, Arroyo Rodríguez JL, Pérez-Olmeda M, Ramos-Martínez A, Velasco-Iglesias A, Bueno Cabrera JL, Duarte RF. Romera Martínez I, et al. Among authors: perez olmeda m. Vox Sang. 2024 Jan;119(1):27-33. doi: 10.1111/vox.13561. Epub 2023 Nov 20. Vox Sang. 2024. PMID: 37986640
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19.
Rodríguez-Mora S, Corona M, Solera Sainero M, Mateos E, Torres M, Sánchez-Menéndez C, Casado-Fernández G, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, Coiras M, García-Gutiérrez V. Rodríguez-Mora S, et al. Among authors: perez olmeda m. Cancers (Basel). 2023 Oct 20;15(20):5066. doi: 10.3390/cancers15205066. Cancers (Basel). 2023. PMID: 37894433 Free PMC article.
West Nile virus emergence in humans in Extremadura, Spain 2020.
Macias A, Martín P, Pérez-Olmeda M, Fernández-Martínez B, Gómez-Barroso D, Fernández E, Ramos JM, Herrero L, Rodríguez S, Delgado E, Sánchez-Seco MP, Galán M, Corbacho AJ, Jimenez M, Montero-Peña C, Valle A, Vázquez A. Macias A, et al. Among authors: perez olmeda m. Front Cell Infect Microbiol. 2023 Jul 4;13:1155867. doi: 10.3389/fcimb.2023.1155867. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37469597 Free PMC article.
Persistent Immunity against SARS-CoV-2 in Individuals with Oncohematological Diseases Who Underwent Autologous or Allogeneic Stem Cell Transplantation after Vaccination.
Rodríguez-Mora S, Pérez-Lamas L, Sainero MS, Torres M, Sánchez-Menéndez C, Corona M, Mateos E, Casado-Fernández G, Alcamí J, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, García-Gutiérrez V, Coiras M. Rodríguez-Mora S, et al. Among authors: perez olmeda m. Cancers (Basel). 2023 Apr 18;15(8):2344. doi: 10.3390/cancers15082344. Cancers (Basel). 2023. PMID: 37190272 Free PMC article.
Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination.
Gonzalez-Perez M, Baranda J, Berges-Buxeda MJ, Conde P, Pérez-Olmeda M, Lozano-Ojalvo D, Cámara C, Del Rosario Llópez-Carratalá M, Gonzalez-Parra E, Portolés P, Ortiz A, Portoles J, Ochando J. Gonzalez-Perez M, et al. Among authors: perez olmeda m. Pharmaceuticals (Basel). 2023 Apr 11;16(4):574. doi: 10.3390/ph16040574. Pharmaceuticals (Basel). 2023. PMID: 37111331 Free PMC article.
Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern.
García-Pérez J, Bermejo M, Ramírez-García A, De La Torre-Tarazona HE, Cascajero A, Castillo de la Osa M, Jiménez P, Aparicio Gómez M, Calonge E, Sancho-López A, Payares-Herrera C, Layunta Acero R, Vicente-Izquierdo L, Avendaño-Solá C, Alcamí J, Pérez-Olmeda M, Díez-Fuertes F. García-Pérez J, et al. Among authors: perez olmeda m. J Med Virol. 2023 Mar;95(3):e28679. doi: 10.1002/jmv.28679. J Med Virol. 2023. PMID: 36929737
Design and Implementation of a Nationwide Population-Based Longitudinal Survey of SARS-CoV-2 Infection in Spain: The ENE-COVID Study.
Pastor-Barriuso R, Pérez-Gómez B, Oteo-Iglesias J, Hernán MA, Pérez-Olmeda M, Fernández-de-Larrea N, Molina M, Fernández-García A, Martín M, Cruz I, Sanmartín JL, León-Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R, Pollán M. Pastor-Barriuso R, et al. Among authors: perez olmeda m. Am J Public Health. 2023 May;113(5):525-532. doi: 10.2105/AJPH.2022.307167. Epub 2023 Mar 9. Am J Public Health. 2023. PMID: 36893375 Free PMC article.
SARS-CoV-2 Infection During the First and Second Pandemic Waves in Spain: the ENE-COVID Study.
Pérez-Gómez B, Pastor-Barriuso R, Fernández-de-Larrea N, Hernán MA, Pérez-Olmeda M, Oteo-Iglesias J, Fernández-Navarro P, Fernández-García A, Martín M, Cruz I, Sanmartín JL, León-Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R, Pollán M. Pérez-Gómez B, et al. Among authors: perez olmeda m. Am J Public Health. 2023 May;113(5):533-544. doi: 10.2105/AJPH.2023.307233. Epub 2023 Mar 9. Am J Public Health. 2023. PMID: 36893370 Free PMC article.
Pathogen reduction with methylene blue does not have an impact on the clinical effectiveness of COVID-19 convalescent plasma.
Romera Martínez I, Bueno Cabrera JL, Domingo-Morera JM, López Aguilar JC, Villegas Da Ros C, García Erce JA, Sáez Serrano I, Flores Ballester E, Maglio LA, Arbona Castaño C, Sola Lapeña C, Guerra Domínguez L, Berberana Fernández M, Madrigal Sánchez ME, Rubio Batllés M, Pérez-Olmeda M, Ramos-Martínez A, Velasco-Iglesias A, Avendaño-Solá C, Duarte RF. Romera Martínez I, et al. Among authors: perez olmeda m. Vox Sang. 2023 Apr;118(4):296-300. doi: 10.1111/vox.13406. Epub 2023 Feb 3. Vox Sang. 2023. PMID: 36734378 Clinical Trial.
60 results